Has Stephen Smith, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,557 in general payments to Stephen Smith, MD across 171 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stephen Smith, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stephen Smith, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stephen Smith, MD

Dermatology · Louisville, KYNPI 1235138009

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (58.1%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 23.2%.

$5,557in general payments, 2019–2025

Across 171 payments — averaging $32.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biofrontera Inc.$1K
Medimetriks Pharmaceuticals, Inc.$796
AbbVie$531
UCB, Inc.$512
Dermavant Sciences, Inc.$500
Sanofi$350
plus $2K from 16 others

$38,891in research payments, 2019–2025

Across 1 payment — averaging $38,891 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Incyte Corporation$39K

What the payments were for

Consulting fees$79614%
Speaking & faculty fees$1,35024%
Food & beverage$3,22858%
Education$1843%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biofrontera Inc.	13	$1,290
Medimetriks Pharmaceuticals, Inc.	2	$796
AbbVie	36	$531
UCB, Inc.	23	$512
Dermavant Sciences, Inc.	33	$500
Sanofi	1	$350
Arcutis Biotherapeutics, Inc.	14	$255
Johnson & Johnson	8	$214
Prugen, Inc. Pharmaceuticals	1	$210
Incyte Corporation	4	$160
Lilly USA, LLC	7	$128
EPI Health, LLC	5	$107
Boehringer Ingelheim	4	$89
Novartis	4	$67
Organon	3	$63
Sun Pharmaceutical Industries Inc.	3	$57
Amgen	3	$55
Smith+Nephew	1	$50
Kyowa Kirin, Inc.	2	$42
Sebela Pharmaceuticals Inc.	2	$40
Regeneron Healthcare Solutions, Inc.	1	$25
Pfizer	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,557 in reported general payments places this provider in the 55th percentile of 128 dermatology providers in Kentucky.

See all dermatology providers in Kentucky →

Medicare billing

Part B allowed, 2024

$892,725

Medicare patients

1,168

Services billed

26,318

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Taltz AutoinjectorIxekizumab	24	$174,368
Ciclopirox	151	$7,153
Mupirocin	524	$5,451
Clobetasol Propionate	76	$5,379
Mometasone Furoate	264	$5,351
Metronidazole	96	$4,758
Betamethasone Dipropionate	87	$4,115
Doxycycline Hyclate	126	$3,216
Desonide	54	$2,786
Fluocinolone Acetonide	52	$2,318
Triamcinolone Acetonide	108	$2,025
ValacyclovirValacyclovir Hcl	52	$1,969
CiclopiroxCiclopirox Olamine	85	$1,762
Halobetasol Propionate	15	$957
Econazole Nitrate	24	$852

Paid to pharmacies, not to this prescriber.

Other dermatology in Louisville

James JacksonLouisville$326K
Jae JungLouisville$188K
Clint TuckerLouisville$50K
Mark WaldmanLouisville$33K
Joseph FowlerLouisville$29K
Shannon EnglandLouisville$20K
Jeffrey CallenLouisville$18K
Ashley BrownLouisville$16K
Todd RickettLouisville$15K
Margaret MoyeLouisville$13K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →